TERRASCEND CORP (TSND.CA) Stock Price, Forecast & Analysis

TSX:TSND • CA88105E1088

1.04 CAD
+0.23 (+28.4%)
Last: Feb 19, 2026, 07:00 PM

TSND.CA Key Statistics, Chart & Performance

Key Statistics
Market Cap386.15M
Revenue(TTM)275.46M
Net Income(TTM)-120.56M
Shares371.30M
Float285.97M
52 Week High2
52 Week Low0.31
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)-0.55
PEN/A
Fwd PEN/A
Earnings (Next)03-12
IPO2017-05-03
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
TSND.CA short term performance overview.The bars show the price performance of TSND.CA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -20 -40

TSND.CA long term performance overview.The bars show the price performance of TSND.CA in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 -20 -40 -60

The current stock price of TSND.CA is 1.04 CAD. In the past month the price decreased by -25%. In the past year, price increased by 2.63%.

TERRASCEND CORP / TSND Daily stock chart

TSND.CA Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to TSND.CA. When comparing the yearly performance of all stocks, TSND.CA turns out to be only a medium performer in the overall market: it outperformed 48.88% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating
TSND.CA Full Technical Analysis Report

TSND.CA Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to TSND.CA. Both the profitability and financial health of TSND.CA have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
TSND.CA Full Fundamental Analysis Report

TSND.CA Financial Highlights

Over the last trailing twelve months TSND.CA reported a non-GAAP Earnings per Share(EPS) of -0.55. The EPS decreased by -25% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -21.71%
ROE -128.44%
Debt/Equity 2.26
Chartmill High Growth Momentum
EPS Q2Q%-14.29%
Sales Q2Q%-12.22%
EPS 1Y (TTM)-25%
Revenue 1Y (TTM)-13.62%
TSND.CA financials

TSND.CA Forecast & Estimates

9 analysts have analysed TSND.CA and the average price target is 1.79 CAD. This implies a price increase of 71.63% is expected in the next year compared to the current price of 1.04.

For the next year, analysts expect an EPS growth of 24.44% and a revenue growth -14.04% for TSND.CA


Analysts
Analysts82.22
Price Target1.79 (72.12%)
EPS Next Y24.44%
Revenue Next Year-14.04%
TSND.CA Analyst EstimatesTSND.CA Analyst Ratings

TSND.CA Ownership

Ownership
Inst Owners38.67%
Ins Owners5.75%
Short Float %N/A
Short RatioN/A
TSND.CA Ownership

TSND.CA Competitors/Peers

The largest stocks on the Canadian markets in the "Pharmaceuticals" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
BHC BAUSCH HEALTH COS INC1.393.156B
CRON CRONOS GROUP INC38.181.388B
TLRY TILRAY BRANDS INC N/A1.213B
DHT-UN DRI HEALTHCARE TRUST7.06884.424M
GUD KNIGHT THERAPEUTICS INC135.28646.681M
WEED CANOPY GROWTH CORP N/A642.424M
NGEN NERVGEN PHARMA CORP N/A458.223M
CPH CIPHER PHARMACEUTICALS INC27.11371.11M
HITI HIGH TIDE INC24.6288.443M

About TSND.CA

Company Profile

TSND logo image TerrAscend Corp. produces and sells medical cannabis products. The company is headquartered in Mississauga, Ontario. The company went IPO on 2017-05-03. The firm has vertically integrated operations in Pennsylvania, New Jersey, Maryland, Ohio, and California through its subsidiary, TerrAscend Growth Corp., along with retail operations in Canada. The firm operates The Apothecarium and other dispensary retail locations as well as scaled cultivation, processing, and manufacturing facilities in its core market. The Company’s cultivation and production methods deliver cannabis, offerring a diverse range of products for both medical and legal adult-use consumers. The company has a variety of product types, including flowers, vaporizable, concentrations, topicals, tinctures, and edibles. The firm owns or licenses several synergistic businesses and brands including The Apothecarium, Cookies, Lemonnade, Ilera Healthcare, Kind Tree, Legend, State Flower, Wana, and Valhalla Confections. The company also operates a cannabis dispensary located in Goshen Township, Ohio.

Company Info

TERRASCEND CORP

3610 Mavis Road

Mississauga ONTARIO CA

Employees: 1057

TSND Company Website

TSND Investor Relations

Phone: 18558377295

TERRASCEND CORP / TSND.CA FAQ

What does TSND do?

TerrAscend Corp. produces and sells medical cannabis products. The company is headquartered in Mississauga, Ontario. The company went IPO on 2017-05-03. The firm has vertically integrated operations in Pennsylvania, New Jersey, Maryland, Ohio, and California through its subsidiary, TerrAscend Growth Corp., along with retail operations in Canada. The firm operates The Apothecarium and other dispensary retail locations as well as scaled cultivation, processing, and manufacturing facilities in its core market. The Company’s cultivation and production methods deliver cannabis, offerring a diverse range of products for both medical and legal adult-use consumers. The company has a variety of product types, including flowers, vaporizable, concentrations, topicals, tinctures, and edibles. The firm owns or licenses several synergistic businesses and brands including The Apothecarium, Cookies, Lemonnade, Ilera Healthcare, Kind Tree, Legend, State Flower, Wana, and Valhalla Confections. The company also operates a cannabis dispensary located in Goshen Township, Ohio.


Can you provide the latest stock price for TERRASCEND CORP?

The current stock price of TSND.CA is 1.04 CAD. The price increased by 28.4% in the last trading session.


Does TSND stock pay dividends?

TSND.CA does not pay a dividend.


What is the ChartMill technical and fundamental rating of TSND stock?

TSND.CA has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


Which stock exchange lists TSND stock?

TSND.CA stock is listed on the Toronto Stock Exchange exchange.